Institutional investors purchased a net $324.0 thousand shares of RMD during the quarter ended December 2017 and now own 65.34% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLI - BANQUE DE LUXEMBOURG INVES... Bought 82.0 Thousand shares of ResMed Inc
ANDRA AP-FONDEN Bought 23.7 Thousand shares of ResMed Inc